Parkinson’s disease is caused by decreased dopamine activity in a brain region. It often has no identifiable trigger, but ...

In December 2025, German developer Limbic Entertainment was sold by Bandai Namco to a "private investor". This news came just over three years after the Japanese giant acquired a majority stake in the ...

Bickerstaff brainstem encephalitis (BBE) is an acute immune-mediated neurological disorder characterized by ophthalmoplegia, ataxia, and impaired consciousness. It overlaps clinically and ...

The Food and Drug Administration (FDA) is tapping Limbic, the maker of an AI-led behavioral health tool, as an early participant in its TEMPO pilot. The Technology-Enabled Meaningful Patient Outcomes ...

Limbic’s Unpacked will be the first company to deliver clinician-supervised AI cognitive behavioral therapy to Medicare patients with depression and anxiety “The shortage of mental health ...

The U.S. Food and Drug Administration (FDA) has selected London-based Limbic as the first AI-led mental healthcare provider for its new Technology-Enabled Meaningful Patient Outcomes (TEMPO) pilot.